Apoptosis

Edited by: Steven Benowitz A. Strasser, A.W. Harris, T. Jacks, S. Cory, "DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2," Cell, 79:329-39, 1994. (Cited in more than 110 publications through October 1996) Comments by Tyler Jacks, Howard Hughes Medical Institute, Massachusetts Institute of Technology Center for Cancer Research; and Andreas Strasser, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia CE

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Edited by: Steven Benowitz
A. Strasser, A.W. Harris, T. Jacks, S. Cory, "DNA damage can induce apoptosis in proliferating lymphoid cells via p53-independent mechanisms inhibitable by Bcl-2," Cell, 79:329-39, 1994. (Cited in more than 110 publications through October 1996) Comments by Tyler Jacks, Howard Hughes Medical Institute, Massachusetts Institute of Technology Center for Cancer Research; and Andreas Strasser, Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia

CELL SLEUTHING: From left, Suzanne Cory, Andreas Strasser, and Alan Harris of the Walter and Eliza Hall Institute of Medical Research study how cells die. The p53 tumor suppressor gene, which is mutated in as many as half of all human cancers, must be functioning for apoptosis-or programmed cell death-to occur when the DNA of immune system cells is damaged by radiation during cancer treatment. If p53 is missing or mutated, apoptosis is inhibited. The oncogene bcl-2, which also is mutated in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies